Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis.
| Autor: | Ying, Min, Zhu, Xiaoxia, Chen, Kexu, Sha, Zhou, Chen, Longhua |
|---|---|
| Zdroj: | Journal of Cancer Research & Clinical Oncology; Aug2015, Vol. 141 Issue 8, p1427-1439, 13p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink